Atlas Trials

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Clinical trial NCT02348008 · COMPLETED

Trial details

NCT number
NCT02348008
Sponsor
Arkadiusz Z. Dudek, MD
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clear Cell Renal Carcinoma
Start date
2015-03-01
Primary completion
2019-12-05
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.